182 related articles for article (PubMed ID: 8686779)
1. Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology.
Murdoch ME; Abiose A; Garate T; Hay RJ; Jones BR; Maizels RM; Parkhouse RM
Am J Trop Med Hyg; 1996 Jun; 54(6):600-12. PubMed ID: 8686779
[TBL] [Abstract][Full Text] [Related]
2. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
3. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch ME; Murdoch IE; Evans J; Yahaya H; Njepuome N; Cousens S; Jones BR; Abiose A
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005489. PubMed ID: 28355223
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IgG isotype responses against Onchocerca volvulus antigens in children in an onchocerciasis-endemic area in northern Nigeria.
Enwezor FN; Nock IH; Edeghere H; Idowu BT; Osue HO; Engelbrecht F
Ann Trop Paediatr; 2000 Jun; 20(2):141-6. PubMed ID: 10945066
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
[TBL] [Abstract][Full Text] [Related]
6. Clinical and parasitological aspects of onchocercal skin diseases in Nigeria.
Dozie IN; Onwuliri CO; Nwoke BE; Onwuliri VA
Trop Doct; 2005 Jul; 35(3):142-4. PubMed ID: 16105335
[TBL] [Abstract][Full Text] [Related]
7. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
[TBL] [Abstract][Full Text] [Related]
8. The profile of IgG and IgG subclasses of onchocerciasis patients.
Dafa'alla TH; Ghalib HW; Abdelmageed A; Williams JF
Clin Exp Immunol; 1992 May; 88(2):258-63. PubMed ID: 1572089
[TBL] [Abstract][Full Text] [Related]
9. Elevated antifilarial IgG4 antibody levels in microfilaremic and microfilaridermic Gabonese adults and children.
Egwang TG; Nguiri C; Kombila M; Duong TH; Richard-Lenoble D
Am J Trop Med Hyg; 1993 Jul; 49(1):135-42. PubMed ID: 8352386
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.
Gbakima AA; Nutman TB; Bradley JE; McReynolds LA; Winget MD; Hong Y; Scott AL
Clin Diagn Lab Immunol; 1996 Jan; 3(1):98-104. PubMed ID: 8770512
[TBL] [Abstract][Full Text] [Related]
11. Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune individuals.
Stewart GR; Elson L; Araujo E; Guderian R; Nutman TB; Bradley JE
Parasite Immunol; 1995 Jul; 17(7):371-80. PubMed ID: 8552410
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
[TBL] [Abstract][Full Text] [Related]
13. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.
Hoffmann WH; Blanke CH; Maier JM; Lüder CG; Schulz-Key H; Soboslay PT
Trop Med Int Health; 1997 Jul; 2(7):635-45. PubMed ID: 9270732
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous pathology in onchocerciasis associated with pronounced systemic T-helper 2-type responses to Onchocerca volvulus.
Timmann C; Abraha RS; Hamelmann C; Buttner DW; Lepping B; Marfo Y; Brattig N; Horstmann RD
Br J Dermatol; 2003 Oct; 149(4):782-7. PubMed ID: 14616370
[TBL] [Abstract][Full Text] [Related]
17. Human isotype antibody responses to an Onchocerca volvulus glutathione S-transferase.
Salinas G; Sinha K; Cooper JP; Whitworth JA; Taylor DW
Parasite Immunol; 1996 Aug; 18(8):377-86. PubMed ID: 9229391
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of a heparan sulfate proteoglycan homologue OvPG-1 from Onchocerca volvulus.
Amambua AN; Ghogomu SM; Tachu JB; Pelle R; Titanji VP
East Afr Med J; 2005 Dec; 82(12):614-24. PubMed ID: 16619705
[TBL] [Abstract][Full Text] [Related]
19. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens.
Boyer AE; Tsang VC; Eberhard ML; Zea-Flores G; Hightower A; Pilcher JB; Zea-Flores R; Zhou W; Reimer CB
J Immunol; 1991 Jun; 146(11):4001-10. PubMed ID: 2033268
[TBL] [Abstract][Full Text] [Related]
20. Identification of Onchocerca volvulus collagen as an antigen mainly recognized by antibodies in chronic hyper-reactive onchodermatitis (sowda).
Garate T; Conraths FJ; Harnett W; Buttner DW; Parkhouse RM
Am J Trop Med Hyg; 1996 May; 54(5):490-7. PubMed ID: 8644904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
